Semnur Pharmaceuticals, Inc. Payments to Acquire Restricted Investments
Semnur Pharmaceuticals, Inc. (SMNR) had Payments to Acquire Restricted Investments of $825.00 thousand as of 2023-04-12, per its 10-Q filed 2023-05-15.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireRestrictedInvestments · last filed 2023-05-15
- Semnur Pharmaceuticals, Inc. payments to acquire restricted investments for the quarter ending 2022-12-31 was $0.00.
- Semnur Pharmaceuticals, Inc. payments to acquire restricted investments for the quarter ending 2022-09-30 was $0.00.
- Semnur Pharmaceuticals, Inc. payments to acquire restricted investments for fiscal 2022 was $84.15M.
| Period end | Payments to Acquire Restricted Investments | Payments to Acquire Restricted Investments 3 month | Payments to Acquire Restricted Investments 6 month | Payments to Acquire Restricted Investments 9 month | Payments to Acquire Restricted Investments 12 month |
|---|---|---|---|---|---|
| 2023-04-12 | $825.00K 10-Q · filed 2023-05-15 | ||||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-17 | $0.00 derived: sum of 2 quarters · filed 2023-03-17 | $84.15M 10-K · filed 2023-03-17 | ||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-16 | $84.15M 10-Q · filed 2022-11-16 | |||
| 2022-06-30 | $84.15M 10-Q · filed 2022-08-12 | ||||
| 2022-04-12 | $825.00K 10-Q · filed 2023-05-15 |